Annual Accounts Receivable
$34.11 M
-$6.11 M-15.20%
December 31, 2023
Summary
- As of February 7, 2025, ATRA annual accounts receivable is $34.11 million, with the most recent change of -$6.11 million (-15.20%) on December 31, 2023.
- During the last 3 years, ATRA annual accounts receivable has risen by +$32.86 million (+2628.64%).
- ATRA annual accounts receivable is now -15.20% below its all-time high of $40.22 million, reached on December 31, 2022.
Performance
ATRA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.33 M
-$1.09 M-44.88%
September 30, 2024
Summary
- As of February 7, 2025, ATRA quarterly accounts receivable is $1.33 million, with the most recent change of -$1.09 million (-44.88%) on September 30, 2024.
- Over the past year, ATRA quarterly accounts receivable has dropped by -$32.77 million (-96.09%).
- ATRA quarterly accounts receivable is now -96.68% below its all-time high of $40.22 million, reached on December 31, 2022.
Performance
ATRA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ATRA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.2% | -96.1% |
| 3 y3 years | +2628.6% | +163.3% |
| 5 y5 years | - | +163.3% |
ATRA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.2% | +3359.2% | -96.7% | +719.0% |
| 5 y | 5-year | -15.2% | -100.0% | -96.7% | -100.0% |
| alltime | all time | -15.2% | -100.0% | -96.7% | -100.0% |
Atara Biotherapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.33 M(-44.9%) |
| Jun 2024 | - | $2.42 M(-93.2%) |
| Mar 2024 | - | $35.83 M(+5.1%) |
| Dec 2023 | $34.11 M(-15.2%) | $34.11 M(>+9900.0%) |
| Sep 2023 | - | $163.00 K(-67.9%) |
| Jun 2023 | - | $507.00 K(+27.7%) |
| Mar 2023 | - | $397.00 K(-99.0%) |
| Dec 2022 | $40.22 M | $40.22 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $249.00 K(-60.9%) |
| Jun 2022 | - | $637.00 K(-4.6%) |
| Mar 2022 | - | $668.00 K(-32.3%) |
| Dec 2021 | $986.00 K(-21.1%) | $986.00 K(>+9900.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Mar 2021 | - | $9.61 M(+668.8%) |
| Dec 2020 | $1.25 M(>+9900.0%) | $1.25 M(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is Atara Biotherapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual accounts receivable year-on-year change?
- What is Atara Biotherapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly accounts receivable year-on-year change?
What is Atara Biotherapeutics annual accounts receivable?
The current annual accounts receivable of ATRA is $34.11 M
What is the all time high annual accounts receivable for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual accounts receivable is $40.22 M
What is Atara Biotherapeutics annual accounts receivable year-on-year change?
Over the past year, ATRA annual accounts receivable has changed by -$6.11 M (-15.20%)
What is Atara Biotherapeutics quarterly accounts receivable?
The current quarterly accounts receivable of ATRA is $1.33 M
What is the all time high quarterly accounts receivable for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly accounts receivable is $40.22 M
What is Atara Biotherapeutics quarterly accounts receivable year-on-year change?
Over the past year, ATRA quarterly accounts receivable has changed by -$32.77 M (-96.09%)